JPMorgan Chase & Co’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-174,264
| Closed | -$3.2M | – | 5541 |
|
|
2020
Q4 | $3.2M | Buy |
174,264
+74,279
| +74% | +$1.37M | ﹤0.01% | 2687 |
|
|
2020
Q3 | $1.83M | Buy |
99,985
+17,431
| +21% | +$319K | ﹤0.01% | 2807 |
|
|
2020
Q2 | $1.24M | Buy |
82,554
+25,852
| +46% | +$387K | ﹤0.01% | 2913 |
|
|
2020
Q1 | $896K | Buy |
56,702
+34,148
| +151% | +$540K | ﹤0.01% | 3005 |
|
|
2019
Q4 | $365K | Buy |
22,554
+18,582
| +468% | +$301K | ﹤0.01% | 3572 |
|
|
2019
Q3 | $59K | Buy |
3,972
+643
| +19% | +$9.55K | ﹤0.01% | 4192 |
|
|
2019
Q2 | $50K | Buy |
3,329
+498
| +18% | +$7.48K | ﹤0.01% | 4254 |
|
|
2019
Q1 | $49K | Sell |
2,831
-132
| -4% | -$2.29K | ﹤0.01% | 4251 |
|
|
2018
Q4 | $52K | Buy |
2,963
+271
| +10% | +$4.76K | ﹤0.01% | 4252 |
|
|
2018
Q3 | $49K | Buy |
2,692
+336
| +14% | +$6.12K | ﹤0.01% | 4362 |
|
|
2018
Q2 | $46K | Buy |
+2,356
| New | +$46K | ﹤0.01% | 4343 |
|